Understanding immunotherapy and its management

    DOI Logo 10.17352/2455-8591.000030

    Published On: January 12, 2021 | Pages: 001 - 007

    Author(s): Nadiminti Rajesh Kumar* and Sajid Alvi
    A few tumours are exceptionally stubborn to oral chemotherapy. The endurance of tumours in a few cases is helped by checkpoint immunomodulation to keep up the unevenness between resistant reconnaissance and disease cell division. Checkpoint counteracting agent inhibitors, for example, against PD-1/PD-L1, are another class of inhibitors that capacity has tumour stiflin ... CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat
    Abstract View Full Article View


    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on IJICR